Drug hypersensitivity reaction Terminated Phase 1 Trials for Miglustat (DB00419)

Also known as: Hypersensitivity reactions / Drug Hypersensitivity / Hypersensitivity Reaction / Drug hypersensitivity reactions / Drug hypersensitivity (& [NOS]) / Drug hypersensitivity NOS / Drug allergy / Allergy / Hypersensitivity NOS / Allergy NOS / Hypersensitivity reaction (NOS) / Reaction hypersensitivity (NOS) / Allergic reaction / Hypersensitivity / Allergic reaction NOS / Reaction allergic (NOS) / Allergic reaction (NOS) / HYSN / Hypersensitivity symptom

IndicationStatusPhase
DBCOND0022247 (Drug hypersensitivity reaction)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02185651A Pilot Study of Zavesca® in Patients With Pompe Disease and Infusion Associated ReactionTreatment